NDC 0093-8121-19 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0093-8121
- Requested NDC
- 0093-8121-19
- Package NDCs from labels
- 0093-8121-19
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2011-12-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - Rebel Distributors Corp | Rebel Distributors Corp | 2011-12-20 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-8121-01 | EA - Each | 0093-8121 | 45649dac-94f6-4290-b479-8756a6201f36 | 1 | 2012-07-24 |
| 0093-8121-19 | EA - Each | 0093-8121 | f8ce4f47-2f2f-42a0-9718-10469d3aba98 | 1 | 2012-07-24 |
| 0093-8121-93 | EA - Each | 0093-8121 | 363647fd-6ac5-4cf0-9eb2-daa8e641c5d8 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXAZOSIN MESYLATE | ACTIVE INGREDIENT | 86P6PQK0MU | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| DOXAZOSIN | ACTIVE MOIETY | NW1291F1W8 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN MESYLATE | Northwind Health Company, LLC | f6c9856e-9154-f349-e053-6294a90a9f2c | 2026-01-19 | Warnings, Adverse reactions | 86P6PQK0MU |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Doxazosin | DOXAZOSIN | Northwind Health Company, LLC | f306adae-a2fe-5477-e053-2995a90a7838 | 2026-01-01 | Warnings, Adverse reactions | 86P6PQK0MU |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 7aeaa0e1-136c-444d-b66c-7a5a96fb3022 | 2025-12-05 | Warnings, Adverse reactions | ANDA075536 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 445dc831-1960-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Upsher-Smith laboratories, LLC | b5d1c604-ce3b-4973-845f-9db267a945cd | 2025-11-12 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | d42d2691-f25d-4dfc-99d0-3286d71480a4 | 2025-10-13 | Warnings, Adverse reactions | ANDA075536 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 57f4a953-ad23-4a44-9956-c48aa5927132 | 2025-10-02 | Warnings, Adverse reactions | ANDA075536 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | American Health Packaging | 3f4dc1a7-05e6-41d7-908c-30ce2677d87b | 2025-09-17 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | b4c974ad-cbd6-4811-ab48-461e7ffa99f7 | 2025-09-17 | Warnings, Adverse reactions | 86P6PQK0MU |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 3ab222b7-74cc-5343-e063-6294a90a9616 | 2025-07-24 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 30b709d6-c438-c721-e063-6294a90abd61 | 2025-03-19 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 2e5cd8cb-7d43-e7af-e063-6294a90a310e | 2025-02-17 | Warnings, Adverse reactions | 86P6PQK0MU |
| DOXAZOSIN | DOXAZOSIN | direct rx | b57cf33b-e0bd-54e9-e053-2a95a90a5a6a | 2025-01-17 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 88efdfb0-710f-768a-e053-2995a90aede4 | 2024-12-17 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Zydus Lifesciences Limited | ac889877-133c-4448-af5a-d77b3cbfe878 | 2024-11-28 | 197626 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.